About Cognate BioServices

Cognate BioServices is a leading contract development and manufacturing organization specialized in cell and cell-mediated gene therapies. We pride ourselves in the level of quality and experience we bring to the table.
Cognate is a dynamic, results-driven, organization focused on providing the broadest range of commercialization services to regenerative medicine, cellular immunotherapy and advance cell therapy companies, organizations and institutions. Cognate provides a unique combination of custom services to companies across all points of clinical and commercial development ranging from early preclinical studies, to mid phase trials and product scale-up though later stage clinical trials and bridging into commercial manufacturing. Cognate applies the know-how and expertise of its business, scientific and technical teams to successfully develop autologous and allogeneic products across multiple cell-based technology platforms from start to finish.

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Location
4600 East Shelby Drive, Suite 108, Memphis, TN 38118, US
description icon
Founded
2002

Cognate BioServices Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
biotechnology

Frequently Asked Questions about Cognate BioServices

Who are the decision makers in Cognate BioServices?

The decision makers in Cognate BioServices are Alan Smith, Bernard Zoppa, Barry Conner, etc. Click to Find Cognate BioServices decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more